Mylan says being investigated over EpiPen practices

From Reuters:

Mylan NV said on Monday U.S. antitrust authorities had launched an investigation into its EpiPen emergency allergy treatment.

The Federal Trade Commission had asked the company for information months ago as part of a preliminary investigation, a company spokesperson said in an email.

The company did not provide any further details on the investigation but said suggestions it took any inappropriate or unlawful actions to prevent generic competition was “without merit.”

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: